From insulin to vaccines, temperature-sensitive products are part of everyday life for many medical professionals and consumers. For pharmaceutical manufacturers, ensuring these products arrive intact and within strict temperature limits is critical. It requires a carefully designed and validated cold chain packaging system, supported by both distribution and cold chain studies. While these studies evaluate different risks, together they prove if the packaging system can survive real-world shipping and maintain product temperature throughout the distribution cycle. With the help of Devon Buckley, Engineering Manager at PCL, we’ll discuss the details of each test method, why they’re important, and which products require these tests for validation.
Cold chain testing is essential for products that are highly sensitive to temperature including:
- Biologics and Injectable Drugs
- Vaccines
- Cell and Gene Therapies
- Temperature-sensitive Medical Devices
These products require cold chain and distribution studies in order to ensure the efficacy of the intended package design.
What Is Distribution Testing?
Distribution studies focus on how a packaging system can handle the distribution process. The goal is to confirm that all components including the shipper, insulation, refrigerants, and internal contents can withstand the hazards encountered during transportation.
Typical distribution testing evaluates exposure to:
- Drops and impacts
- Vibration during transit
- Compression and stacking forces
- Handling and orientation changes
The outcome of distribution testing is confidence that the package will remain intact and maintain its intended configuration throughout shipment. Running the intended packaging design through ASTM D3103 is critical because even minor damage or internal disruption can compromise thermal performance.
What Is Cold Chain Testing?
Cold chain studies, or ISTA 7D, evaluate the thermal performance of the packaging system. Using controlled temperature profiles, these studies confirm the system’s ability to maintain required temperature ranges over a defined shipment duration.
Cold chain testing assesses:
- Performance under hot and cold conditions
- Seasonal temperature extremes
- Duration limits of refrigerants and insulation
- Stability across shipping timelines
The result is documented evidence that the packaging configuration can protect temperature-sensitive products when exposed to real-world environmental conditions.
Why Both Studies Are Necessary
Temperature-sensitive products are vulnerable to multiple failure modes during transportation. Without proper testing, failures can occur with no visible signs until product is compromised.
Distribution and cold chain studies are designed to evaluate different risks, but together they provide a complete performance picture. Distribution testing demonstrates that the packaging system can survive real-world handling and transport stresses. Cold chain testing demonstrates that the same system can maintain temperature control when exposed to environmental extremes. Combined, they confirm that thermal performance is preserved throughout the entire distribution cycle.
A package that performs well thermally but fails distribution testing is just as risky as a durable package that cannot maintain temperature.
How Are These Studies Commonly Performed?
Cold chain and distribution testing are typically performed as separate but coordinated tests, since they require different test environments.
In many cases, distribution testing is performed first to confirm the packaging system can withstand drops, vibration, and compression. This helps identify potential damage or internal insulation disruption before thermal performance is evaluated. Cold chain testing follows, using the same packaging configuration to verify temperature control under defined thermal profiles.
Because of the differing test requirements, these studies are often conducted on separate but equivalent sample sets. Together, they provide complementary evidence that the packaging system can both survive distribution and maintain the correct temperature throughout shipment.
Common Mistakes to Avoid
Even well-designed studies can fall short if key factors are overlooked. Common pitfalls include:
- Focusing only on temperature data
Thermal performance is only meaningful if the package remains intact throughout shipment. Ignoring distribution hazards can mask real-world failure risks.
- Not testing worst-case conditions
Failing to account for worst-case conditions can result in a validation that looks compliant on paper but fails in practice.
Avoiding these mistakes helps ensure that testing reflects how products are actually shipped, not just how they are expected to perform in controlled scenarios.
Key Takeaways
Cold chain and distribution studies are not competing evaluations, they are complementary tests. When performed together, they demonstrate that a temperature-controlled packaging system can endure the physical realities of transport while consistently protecting product temperature.
For manufacturers of vaccines, biologics, diagnostics, and other temperature-sensitive products, this combined approach is essential to safeguarding product quality, meeting regulatory expectations, and ultimately protecting patient safety.
If you found this helpful, we share insights like this on LinkedIn every week. Follow us there to keep the conversation going.
You can also explore more resources and services on our website.
